Multiple‐Targeting and Conformational Selection in the Estrogen Receptor: Computation and Experiment
暂无分享,去创建一个
R. Nussinov | B. Ma | Jian Huang | Kaiwei Liang | P. Yuan | Nan Zheng
[1] Ruben Abagyan,et al. Improved docking, screening and selectivity prediction for small molecule nuclear receptor modulators using conformational ensembles , 2010, J. Comput. Aided Mol. Des..
[2] S. Ozkan,et al. A flexible docking scheme to explore the binding selectivity of PDZ domains , 2010, Protein science : a publication of the Protein Society.
[3] Martin Zacharias,et al. Accounting for conformational changes during protein-protein docking. , 2010, Current opinion in structural biology.
[4] Amy C. Anderson,et al. Scoring Ensembles of Docked Protein: Ligand Interactions for Virtual Lead Optimization , 2009, J. Chem. Inf. Model..
[5] S. Salvadori,et al. Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile. , 2009, British journal of anaesthesia.
[6] T. Rajah,et al. Genistein in the Presence of 17β-Estradiol Inhibits Proliferation of ERβ Breast Cancer Cells , 2009, Pharmacology.
[7] Ruth Nussinov,et al. Amplification of signaling via cellular allosteric relay and protein disorder , 2009, Proceedings of the National Academy of Sciences.
[8] Ajay N. Jain. Effects of protein conformation in docking: improved pose prediction through protein pocket adaptation , 2009, J. Comput. Aided Mol. Des..
[9] Chung F. Wong,et al. Conformational selection of protein kinase A revealed by flexible‐ligand flexible‐protein docking , 2009, J. Comput. Chem..
[10] Yan Zhu,et al. The anti-inflammatory activities of Tanshinone IIA, an active component of TCM, are mediated by estrogen receptor activation and inhibition of iNOS , 2009, The Journal of Steroid Biochemistry and Molecular Biology.
[11] M. Takiguchi,et al. Insight into estrogenicity of phytoestrogens using in silico simulation. , 2009, Biochemical and biophysical research communications.
[12] Jian Huang,et al. A Bipartite Recombinant Yeast System for the Identification of Subtype-Selective Estrogen Receptor Ligands , 2009, Molecular biotechnology.
[13] H. Wolfson,et al. Principles of flexible protein–protein docking , 2008, Proteins.
[14] Adriano D. Andricopulo,et al. Structure-Based Approach for the Study of Estrogen Receptor Binding Affinity and Subtype Selectivity , 2008, J. Chem. Inf. Model..
[15] D. Dixon,et al. A low concentration of genistein induces estrogen receptor-alpha and insulin-like growth factor-I receptor interactions and proliferation in uterine leiomyoma cells. , 2008, Human reproduction.
[16] L. Cubano,et al. Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model. , 2008, Translational oncology.
[17] Ram Samudrala,et al. Novel paradigms for drug discovery: computational multitarget screening. , 2008, Trends in pharmacological sciences.
[18] T. Hei,et al. Phytoestrogens and Breast Cancer Prevention: Possible Mechanisms of Action , 2008, Environmental health perspectives.
[19] Andrzej Joachimiak,et al. Structural plasticity in the oestrogen receptor ligand‐binding domain , 2007, EMBO reports.
[20] C. E. Peishoff,et al. A critical assessment of docking programs and scoring functions. , 2006, Journal of medicinal chemistry.
[21] Takeshi Usui,et al. Pharmaceutical prospects of phytoestrogens. , 2006, Endocrine journal.
[22] N. Shah,et al. Postmenopausal hormone therapy and breast cancer: a systematic review and meta-analysis , 2005, Menopause.
[23] F. Stossi,et al. Synthesis and evaluation of estrogen receptor ligands with bridged oxabicyclic cores containing a diarylethylene motif: estrogen antagonists of unusual structure. , 2005, Journal of medicinal chemistry.
[24] D. Heber,et al. Phytoestrogens Induce Differential Estrogen Receptor Alpha- or Beta-Mediated Responses in Transfected Breast Cancer Cells , 2005, Experimental biology and medicine.
[25] M. Malamas,et al. Estrogen receptor ligands: design and synthesis of new 2-arylindene-1-ones. , 2005, Bioorganic & medicinal chemistry letters.
[26] J. Keith,et al. ERbeta ligands. 3. Exploiting two binding orientations of the 2-phenylnaphthalene scaffold to achieve ERbeta selectivity. , 2005, Journal of medicinal chemistry.
[27] A. Scorilas,et al. Polyadenylate polymerase modulations in human epithelioid cervix and breast cancer cell lines, treated with etoposide or cordycepin, follow cell cycle rather than apoptosis induction , 2005, Biological chemistry.
[28] Fabio Stossi,et al. Indazole estrogens: highly selective ligands for the estrogen receptor beta. , 2005, Journal of medicinal chemistry.
[29] Péter Csermely,et al. The efficiency of multi-target drugs: the network approach might help drug design. , 2004, Trends in pharmacological sciences.
[30] Eric S Manas,et al. Structure-based design of estrogen receptor-beta selective ligands. , 2004, Journal of the American Chemical Society.
[31] David H. Kaufman,et al. 7-Substituted 2-phenyl-benzofurans as ERβ selective ligands , 2004 .
[32] Iwan Gunawan,et al. Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands. , 2004, Journal of medicinal chemistry.
[33] Fabio Stossi,et al. Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: distinct and common target genes for these receptors. , 2004, Endocrinology.
[34] S. O. Mueller,et al. Phytoestrogens and Their Human Metabolites Show Distinct Agonistic and Antagonistic Properties on Estrogen Receptor α (ERα)and ERβ in Human Cells , 2004 .
[35] Eric S Manas,et al. ERbeta ligands. Part 2: Synthesis and structure-activity relationships of a series of 4-hydroxy-biphenyl-carbaldehyde oxime derivatives. , 2004, Bioorganic & medicinal chemistry.
[36] Y. Liang,et al. Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats , 2004, Neuroscience Letters.
[37] Matthew P. Repasky,et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.
[38] Hege S. Beard,et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.
[39] John A. Katzenellenbogen,et al. Allosteric Control of Ligand Selectivity between Estrogen Receptors α and β - Implications for Other Nuclear Receptors , 2004 .
[40] Ajay N. Jain,et al. Ligand-based structural hypotheses for virtual screening. , 2004, Journal of medicinal chemistry.
[41] Nico P E Vermeulen,et al. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method. , 2004, Journal of medicinal chemistry.
[42] Vincent W DeLaGarza,et al. Genetic Predisposition and Environmental Pharmacologic Treatment of Alzheimer's Disease: an Update Clinical Pharmacology , 2022 .
[43] B. Katzenellenbogen,et al. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression , 2003, Molecular and Cellular Endocrinology.
[44] Eric S Manas,et al. ERβ Ligands. Part 1: The discovery of ERβ selective ligands which embrace the 4-hydroxy-biphenyl template , 2003 .
[45] S. Apers,et al. Phytoestrogens: Recent Developments , 2003, Planta medica.
[46] Peter Wolohan,et al. CoMFA and docking study of novel estrogen receptor subtype selective ligands , 2003, J. Comput. Aided Mol. Des..
[47] Y. Lavy,et al. [Review of risk factors for breast cancer--what's new?]. , 2002, Harefuah.
[48] T. Matsumiya,et al. Effects of osthole on postmenopausal osteoporosis using ovariectomized rats; comparison to the effects of estradiol. , 2002, Biological & pharmaceutical bulletin.
[49] Tomomi Sato,et al. The phytoestrogen genistein induces thymic and immune changes: A human health concern? , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[50] David A. Agard,et al. Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism , 2002, Nature Structural Biology.
[51] H. Wolfson,et al. Access the most recent version at doi: 10.1110/ps.21302 References , 2001 .
[52] B. Katzenellenbogen,et al. Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. , 2001, Journal of medicinal chemistry.
[53] N. Cutler,et al. Review of the acetylcholinesterase inhibitor galanthamine , 2000, Expert opinion on investigational drugs.
[54] J. Gustafsson,et al. Estrogen receptor beta--a new dimension in estrogen mechanism of action. , 1999, The Journal of endocrinology.
[55] M Carlquist,et al. Structure of the ligand‐binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist , 1999, The EMBO journal.
[56] M. Parker,et al. Molecular Determinants of the Estrogen Receptor-Coactivator Interface , 1999, Molecular and Cellular Biology.
[57] David A. Agard,et al. The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen , 1998, Cell.
[58] J. Gustafsson,et al. The Estrogen Receptor β Subtype: A Novel Mediator of Estrogen Action in Neuroendocrine Systems , 1998, Frontiers in Neuroendocrinology.
[59] J. Gustafsson,et al. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. , 1998, Molecular pharmacology.
[60] J. Lehmann,et al. Cloning and Characterization of Human Estrogen Receptor β Isoforms , 1998 .
[61] B. Shoichet,et al. Flexible ligand docking using conformational ensembles , 1998, Protein science : a publication of the Protein Society.
[62] J. Gustafsson,et al. Characterization of bacterially expressed rat estrogen receptor β ligand binding domain by mass spectrometry: Structural comparison with estrogen receptor α , 1997, Steroids.
[63] K. Setchell,et al. Exposure of infants to phyto-oestrogens from soy-based infant formula , 1997, The Lancet.
[64] P. Leff,et al. The two-state model of receptor activation. , 1995, Trends in pharmacological sciences.
[65] D Rodbard,et al. Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. , 1992, Molecular pharmacology.
[66] T. Kenakin,et al. Theoretical effects of single and multiple transducer receptor coupling proteins on estimates of the relative potency of agonists. , 1989, Molecular pharmacology.
[67] Joseph P. Salisbury,et al. Docking study of triphenylphosphonium cations as estrogen receptor alpha modulators. , 2009 .
[68] R. Limberger,et al. Screening for in vivo (anti)estrogenic activity of ephedrine and p-synephrine and their natural sources Ephedra sinica Stapf. (Ephedraceae) and Citrus aurantium L. (Rutaceae) in rats , 2008, Archives of Toxicology.
[69] K. Kang,et al. Estrogenic activities of isoflavones and flavones and their structure-activity relationships. , 2008, Planta medica.
[70] H. Harris. Preclinical characterization of selective estrogen receptor beta agonists: new insights into their therapeutic potential. , 2006, Ernst Schering Foundation symposium proceedings.
[71] R. Henderson,et al. 7-Substituted 2-phenyl-benzofurans as ER beta selective ligands. , 2004, Bioorganic & medicinal chemistry letters.
[72] B. Katzenellenbogen,et al. Allosteric control of ligand selectivity between estrogen receptors alpha and beta: implications for other nuclear receptors. , 2004, Molecular cell.
[73] S. O. Mueller,et al. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[74] H. Harris,et al. ERbeta ligands. Part 1: the discovery of ERbeta selective ligands which embrace the 4-hydroxy-biphenyl template. , 2003, Bioorganic & medicinal chemistry.
[75] J. Lehmann,et al. Cloning and characterization of human estrogen receptor beta isoforms. , 1998, Biochemical and biophysical research communications.
[76] J. Gustafsson,et al. Characterization of bacterially expressed rat estrogen receptor beta ligand binding domain by mass spectrometry: structural comparison with estrogen receptor alpha. , 1997, Steroids.